The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis
Abstract
BACKGROUND AND AIMS Pathological bacterial translocation (PBT) in liver cirrhosis (LC) is the hallmark for spontaneous bacterial infections increasing mortality several-fold. Factors known to contribute to PBT in LC are among others an increased intestinal permeability of which however, the mucus layer has not been addressed so far in detail. A clear route of translocation for luminal intestinal bacteria is yet to be defined but we hypothesize that the recently described gut vascular barrier (GVB) is impaired in experimental portal hypertension leading to increased accessibility of the vascular compartment for translocating bacteria. RESULTS Healthy and pre-hepatic portal-hypertensive (PPVL) mice lack translocation of FITC-dextran and GFP-Escherichia coli from the small intestine to the liver whereas bile-duct-ligated (BDL) and CCl4-induced cirrhotic mice demonstrate pathological translocation which is not altered by prior thoracic-duct ligation. Mucus layer is reduced in thickness with loss of goblet-cells and Muc2-staining and expression in cirrhotic but not PPVL-mice associated with bacterial overgrowth in inner mucus layer and pathological translocation of GFP-E.coli through the ileal epithelium. GVB is profoundly altered in BDL and CCl4-mice with Ileal extravasation of large-sized 150 kDa-FITC-dextran but only minor in PPVL-mice. This pathological endothelial permeability and accessibility in cirrhotic mice associates with an augmented expression of PV1 in intestinal vessels. OCA but not fexaramine stabilizes the GVB whereas both FXR-agonists ameliorate gut-liver-translocation of GFP-E.coli. CONCLUSIONS Liver cirrhosis but not portal hypertension per se grossly impairs the endothelial and muco-epithelial barriers promoting PBT to the portal-venous circulation. Both barriers appear FXR-modulated with -agonists reducing PBT via the portal-venous route. LAY SUMMARY For intestinal bacteria to enter the systemic circulation crossing of mucus and epithelial layer as well as gut-vascular-barrier (GVB) is necessary. Liver cirrhosis disrupts all three of these barriers giving bacteria access to the portal-venous circulation and thus, gut-liver-axis. Diminished luminal bile acid availability featuring cirrhosis and associated reduced signaling known to involve the farnesoid-x-receptor (FXR) seems at least partly to mediate these changes since FXR-agonists reduce bacterial translocation via the portal-venous route to the liver in cirrhosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
Johansson, M. E. V., Phillipson, M., Petersson, J., Velcich, A., Holm, L., & Hansson, G. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803124105 · Cited by 2,200
Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
Jia, W., Xie, G., & Jia, W. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.119 · Cited by 1,924
Van der Sluis, M., De Koning, B. A. E., De Bruijn, A. C. J. M., Velcich, A., Meijerink, J. P. P., Van Goudoever, J. B., Büller, H. A., Dekker, J., Van Seuningen, I., Renes, I. B., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.020 · Cited by 1,684
The gastrointestinal mucus system in health and disease
Johansson, M. E. V., Sjövall, H., & Hansson, G. C. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.35 · Cited by 1,438
Pelaseyed, T., Bergström, J. H., Gustafsson, J. K., Ermund, A., Birchenough, G. M. H., Schütte, A., van der Post, S., Svensson, F., Rodríguez‐Piñeiro, A. M., Nyström, E. E. L., et al. (2014) · Immunological Reviews · doi:10.1111/imr.12182 · Cited by 1,363
Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor
Inagaki, T., Moschetta, A., Lee, Y.-K., Peng, L., Zhao, G., Downes, M., Yu, R. T., Shelton, J. M., Richardson, J. A., Repa, J. J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509592103 · Cited by 1,164
Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells
Stappenbeck, T. S., Hooper, L. V., & Gordon, J. I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202604299 · Cited by 1,095
Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013
Jalan, R., Fernandez, J., Wiest, R., Schnabl, B., Moreau, R., Angeli, P., Stadlbauer, V., Gustot, T., Bernardi, M., Canton, R., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.01.024 · Cited by 906
Self-citationGadaleta, R. M., van Erpecum, K. J., Oldenburg, B., Willemsen, E. C. L., Renooij, W., Murzilli, S., Klomp, L. W. J., Siersema, P. D., Schipper, M. E. I., Danese, S., et al. (2011) · Gut · doi:10.1136/gut.2010.212159 · Cited by 870
Wnt/β-catenin signaling controls development of the blood–brain barrier
Liebner, S., Corada, M., Bangsow, T., Babbage, J., Taddei, A., Czupalla, C. J., Reis, M., Felici, A., Wolburg, H., Fruttiger, M., et al. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200806024 · Cited by 860
New developments in goblet cell mucus secretion and function
Birchenough, G. M. H., Johansson, M. E., Gustafsson, J. K., Bergström, J. H., & Hansson, G. C. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.32 · Cited by 815
Pathological bacterial translocation in liver cirrhosis
Wiest, R., Lawson, M., & Geuking, M. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.07.044 · Cited by 805
Self-citationPellicciari, R., Fiorucci, S., Camaioni, E., Clerici, C., Costantino, G., Maloney, P. R., Morelli, A., Parks, D. J., & Willson, T. M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm025529g · Cited by 743
Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
Fang, S., Suh, J. M., Reilly, S. M., Yu, E., Osborn, O., Lackey, D., Yoshihara, E., Perino, A., Jacinto, S., Lukasheva, Y., et al. (2015) · Nature Medicine · doi:10.1038/nm.3760 · Cited by 738
The composition of the gut microbiota shapes the colon mucus barrier
Jakobsson, H. E., Rodríguez‐Piñeiro, A. M., Schütte, A., Ermund, A., Boysen, P., Bemark, M., Sommer, F., Bäckhed, F., Hansson, G. C., & Johansson, M. E. (2015) · The EMBO Reports · doi:10.15252/embr.201439263 · Cited by 700
A gut-vascular barrier controls the systemic dissemination of bacteria
Spadoni, I., Zagato, E., Bertocchi, A., Paolinelli, R., Hot, E., Di Sabatino, A., Caprioli, F., Bottiglieri, L., Oldani, A., Viale, G., et al. (2015) · Science · doi:10.1126/science.aad0135 · Cited by 695
Self-citationBacterial translocation (BT) in cirrhosis†
Wiest, R., & Garcia‐Tsao, G. (2005) · Hepatology · doi:10.1002/hep.20632 · Cited by 677
Self-citationBergstrom, K. S. B., Kissoon-Singh, V., Gibson, D. L., Ma, C., Montero, M., Sham, H. P., Ryz, N., Huang, T., Velcich, A., Finlay, B. B., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000902 · Cited by 625
Fernández, M., Semela, D., Bruix, J., Colle, I., Pinzani, M., & Bosch, J. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.011 · Cited by 600
A sentinel goblet cell guards the colonic crypt by triggering Nlrp6-dependent Muc2 secretion
Birchenough, G. M. H., Nyström, E. E. L., Johansson, M. E. V., & Hansson, G. C. (2016) · Science · doi:10.1126/science.aaf7419 · Cited by 568
The outer mucus layer hosts a distinct intestinal microbial niche
Li, H., Limenitakis, J. P., Fuhrer, T., Geuking, M. B., Lawson, M. A., Wyss, M., Brugiroux, S., Keller, I., Macpherson, J. A., Rupp, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms9292 · Cited by 511
Self-citationBrugiroux, S., Beutler, M., Pfann, C., Garzetti, D., Ruscheweyh, H.-J., Ring, D., Diehl, M., Herp, S., Lötscher, Y., Hussain, S., et al. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.215 · Cited by 476
Targeting the gut-liver axis in liver disease
Wiest, R., Albillos, A., Trauner, M., Bajaj, J. S., & Jalan, R. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.007 · Cited by 419
Self-citationA Chemical, Genetic, and Structural Analysis of the Nuclear Bile Acid Receptor FXR
Downes, M., Verdecia, M. A., Roecker, A. J., Hughes, R., Hogenesch, J. B., Kast-Woelbern, H. R., Bowman, M. E., Ferrer, J.-L., Anisfeld, A. M., Edwards, P. A., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00104-7 · Cited by 390
Sodhi, C. P., Neal, M. D., Siggers, R., Sho, S., Ma, C., Branca, M. F., Prindle, T., Russo, A. M., Afrazi, A., Good, M., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.053 · Cited by 318
Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease
Fouts, D. E., Torralba, M., Nelson, K. E., Brenner, D. A., & Schnabl, B. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.01.019 · Cited by 311
Wiest, R., Das, S., Cadelina, G., Garcia-Tsao, G., Milstien, S., & Groszmann, R. J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7458 · Cited by 306
Self-citationMicrobial sensing by goblet cells controls immune surveillance of luminal antigens in the colon
Knoop, K. A., McDonald, K. G., McCrate, S., McDole, J. R., & Newberry, R. D. (2015) · Mucosal Immunology · doi:10.1038/mi.2014.58 · Cited by 275
Modica, S., Petruzzelli, M., Bellafante, E., Murzilli, S., Salvatore, L., Celli, N., Di Tullio, G., Palasciano, G., Moustafa, T., Halilbasic, E., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.10.028 · Cited by 275
Corfield, A. P., Wagner, S. A., Clamp, J. R., Kriaris, M. S., & Hoskins, L. C. (1992) · Infection and Immunity · doi:10.1128/iai.60.10.3971-3978.1992 · Cited by 266
Verbeke, L., Farre, R., Trebicka, J., Komuta, M., Roskams, T., Klein, S., Elst, I. V., Windmolders, P., Vanuytsel, T., Nevens, F., et al. (2014) · Hepatology · doi:10.1002/hep.26939 · Cited by 258
Llorente, C., Jepsen, P., Inamine, T., Wang, L., Bluemel, S., Wang, H. J., Loomba, R., Bajaj, J. S., Schubert, M. L., Sikaroodi, M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00796-x · Cited by 257
Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice
Hartmann, P., Chen, P., Wang, H. J., Wang, L., McCole, D. F., Brandl, K., Stärkel, P., Belzer, C., Hellerbrand, C., Tsukamoto, H., et al. (2013) · Hepatology · doi:10.1002/hep.26321 · Cited by 246
The Diaphragms of Fenestrated Endothelia: Gatekeepers of Vascular Permeability and Blood Composition
Stan, R. V., Tse, D., Deharvengt, S. J., Smits, N. C., Xu, Y., Luciano, M. R., McGarry, C. L., Buitendijk, M., Nemani, K. V., Elgueta, R., et al. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.11.003 · Cited by 232
Verbeke, L., Farre, R., Verbinnen, B., Covens, K., Vanuytsel, T., Verhaegen, J., Komuta, M., Roskams, T., Chatterjee, S., Annaert, P., et al. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.10.009 · Cited by 225
Maran, R. R. M., Thomas, A., Roth, M., Sheng, Z., Esterly, N., Pinson, D., Gao, X., Zhang, Y., Ganapathy, V., Gonzalez, F. J., et al. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.145409 · Cited by 220
Johansson, M. E. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041009 · Cited by 207
Gut microflora in the pathogenesis of the complications of cirrhosis
Garcia-Tsao, G., & Wiest, R. (2004) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2003.10.005 · Cited by 190
Self-citationSchütte, A., Ermund, A., Becker-Pauly, C., Johansson, M. E. V., Rodriguez-Pineiro, A. M., Bäckhed, F., Müller, S., Lottaz, D., Bond, J. S., & Hansson, G. C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1407597111 · Cited by 189
Úbeda, M., Lario, M., Muñoz, L., Borrero, M.-J., Rodríguez-Serrano, M., Sánchez-Díaz, A.-M., del Campo, R., Lledó, L., Pastor, Ó., García-Bermejo, L., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.12.010 · Cited by 178
Self-citationSchwabl, P., Hambruch, E., Seeland, B. A., Hayden, H., Wagner, M., Garnys, L., Strobel, B., Schubert, T.-L., Riedl, F., Mitteregger, D., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.12.005 · Cited by 178
Circulating microbiome in blood of different circulatory compartments
Schierwagen, R., Silva, M. C. A., Madsen, M. S. A., Kolbe, C. C., Meyer, C. H., Thomas, D., Uschner, F. E., Magdaleno, F., Jansen, C., Pohlmann, A., et al. (2018) · Gut · doi:10.1136/gutjnl-2018-316227 · Cited by 167
Impaired responsiveness to angiotensin II in experimental cirrhosis: Role of nitric oxide
Castro, A., Jiménez, W., Clária, J., Ros, J., Martínez, J. M., Bosch, M., Arroyo, V., Piulats, J., River, F., & Rodés, J. (1993) · Hepatology · doi:10.1002/hep.1840180221 · Cited by 163
Uchimura, Y., Fuhrer, T., Li, H., Lawson, M. A., Zimmermann, M., Yilmaz, B., Zindel, J., Ronchi, F., Sorribas, M., Hapfelmeier, S., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.08.004 · Cited by 153
Self-citationPV1 Is a Key Structural Component for the Formation of the Stomatal and Fenestral Diaphragms
Stan, R. V., Tkachenko, E., & Niesman, I. R. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-08-0593 · Cited by 150
Downregulation of Endothelin-1 by Farnesoid X Receptor in Vascular Endothelial Cells
He, F., Li, J., Mu, Y., Kuruba, R., Ma, Z., Wilson, A. S., Alber, S. M., Jiang, Y., Stevens, T., Watkins, S. C., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000200400.55539.85 · Cited by 144
Defenders and Challengers of Endothelial Barrier Function
Rahimi, N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01847 · Cited by 142
Kandori, H., Hirayama, K., TAKEDA, M., & Doi, K. (1996) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.45.155 · Cited by 138
A novel model of CCl4-induced cirrhosis with ascites in the mouse
Domenicali, M., Caraceni, P., Giannone, F. A., Baldassarre, M., Lucchetti, G., Quarta, C., Patti, C., Catani, L., Nanni, C., Lemoli, R. M., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.09.008 · Cited by 133
Animal models of portal hypertension
Abraldeṣ, J. G., Pasarin, M., & García-Pagán, J.-C. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i41.6577 · Cited by 125
Strickland, L. A., Jubb, A. M., Hongo, J.-A. S., Zhong, F., Burwick, J. A., Fu, L., Frantz, G. D., & Koeppen, H. (2005) · The Journal of Pathology · doi:10.1002/path.1805 · Cited by 122
Sepsis in alcohol-related liver disease
Gustot, T., Fernández, J., Szabó, G., Albillos, A., Louvet, A., Jalan, R., Moreau, R., & Moreno, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.06.013 · Cited by 118
Self-citationWiest, R., Cadelina, G. W., Milstien, S., McCuskey, R. S., García–Tsao, G., & Groszmann, R. J. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.039 · Cited by 103
Self-citationOctreotide potentiates PKC-dependent vasoconstrictors in portal-hypertensive and control rats
Wiest, R., Tsai, M., & Groszmann, R. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.22529 · Cited by 98
Self-citationSplenic dendritic cell involvement in FXR-mediated amelioration of DSS colitis
Massafra, V., Ijssennagger, N., Plantinga, M., Milona, A., Pittol, J. M. R., Boes, M. L., & van Mil, S. W. C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.11.001 · Cited by 85
Plasmalemma Vesicle–Associated Protein Has a Key Role in Blood-Retinal Barrier Loss
Wisniewska‐Kruk, J., van der Wijk, A., van Veen, H. A., Gorgels, T. G. M. F., Vogels, I. M. C., Versteeg, D., Noorden, C. J. F. V., Schlingemann, R. O., & Klaassen, I. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.11.019 · Cited by 73
Renga, B., Cipriani, S., Carino, A., Simonetti, M., Zampella, A., & Fiorucci, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141082 · Cited by 67
Splanchnic and Systemic Vasodilation: The Experimental Models
Wiest, R. (2007) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318157cb57 · Cited by 42
Self-citationOne technique, two approaches, and results: Thoracic duct cannulation in small laboratory animals
Ionac, M. E. (2003) · Microsurgery · doi:10.1002/micr.10136 · Cited by 42
Bile acid metabolism in cirrhosis
Schwartz, C. C., Almond, H. R., Vlahčevič, Z. R., & Swell, L. (1979) · Gastroenterology · doi:10.1016/0016-5085(79)90154-9 · Cited by 36
Renga, B., D’Amore, C., Cipriani, S., Mencarelli, A., Carino, A., Sepe, V., Zampella, A., Distrutti, E., & Fiorucci, S. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.08.008 · Cited by 22
Roda, A., Aldini, R., Camborata, C., Spinozzi, S., Franco, P., Cont, M., D’Errico, A., Vasuri, F., Degiovanni, A., Maroni, L., et al. (2017) · Clinical and Translational Science · doi:10.1111/cts.12468 · Cited by 18
Cited by
The gut-liver axis in liver disease: Pathophysiological basis for therapy
Albillos, A., de Gottardi, A., & Rescigno, M. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.003 · Cited by 2,166
Self-citationGut-liver axis: Pathophysiological concepts and clinical implications
Tilg, H., Adolph, T. E., & Trauner, M. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.09.017 · Cited by 843
The gut–liver axis and gut microbiota in health and liver disease
Hsu, C. L., & Schnabl, B. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00904-3 · Cited by 737
Intestinal Barrier in Human Health and Disease
Di Tommaso, N., Gasbarrini, A., & Ponziani, F. R. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182312836 · Cited by 533
Gut microbiome, liver immunology, and liver diseases
Wang, R., Tang, R., Li, B., Ma, X., Schnabl, B., & Tilg, H. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00592-6 · Cited by 466
Metadata
- Authors
- Sorribas, M., Jakob, M. O., Yilmaz, B., Li, H., Stutz, D., Noser, Y., de Gottardi, A., Moghadamrad, S., Hassan, M., Albillos, A., Francés, R., Juanola, O., Spadoni, I., Rescigno, M., & Wiest, R.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2019-12
- Volume
- 71
- Issue
- 6
- Pages
- 1126-1140
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2957171936
- Cited by
- 253
- References
- 62
- FWCI
- 14.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.